Difficulty: Medium
Average Score: 70%
Practice
A ganglioblocking drug for hypertension treatment is:
Correct answer
C
Rationale
In this question, the correct answer is C) Trimethaphan, a ganglioblocking drug used for hypertension treatment.
Trimethaphan acts by blocking ganglionic nicotinic cholinergic receptors, leading to decreased sympathetic and parasympathetic tone, ultimately reducing blood pressure.
Option A) Hydralazine is a direct vasodilator that works on arterioles, not through ganglioblocking mechanisms. Option B) Tubocurarine is a neuromuscular blocking agent used during surgery and not for hypertension. Option D) Metoprolol is a beta-blocker that acts on adrenergic receptors, not ganglionic receptors.
In an educational context, understanding the mechanism of action of antihypertensive drugs is crucial for safe and effective medication administration. Knowing the specific actions of each drug helps healthcare providers make informed decisions when managing patients with hypertension. It also emphasizes the importance of matching the drug's mechanism of action with the patient's condition for optimal treatment outcomes.
Trimethaphan acts by blocking ganglionic nicotinic cholinergic receptors, leading to decreased sympathetic and parasympathetic tone, ultimately reducing blood pressure.
Option A) Hydralazine is a direct vasodilator that works on arterioles, not through ganglioblocking mechanisms. Option B) Tubocurarine is a neuromuscular blocking agent used during surgery and not for hypertension. Option D) Metoprolol is a beta-blocker that acts on adrenergic receptors, not ganglionic receptors.
In an educational context, understanding the mechanism of action of antihypertensive drugs is crucial for safe and effective medication administration. Knowing the specific actions of each drug helps healthcare providers make informed decisions when managing patients with hypertension. It also emphasizes the importance of matching the drug's mechanism of action with the patient's condition for optimal treatment outcomes.